Literature DB >> 13642012

The action of N-2-fluorenylacetamide in the Syrian golden hamster.

G DELLA PORTA, P SHUBIK, V SCORTECCI.   

Abstract

Entities:  

Keywords:  FLUORENE/related compounds

Mesh：

Substances：

Year:  1959        PMID： 13642012

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Synergistic effect of ferric oxide on dimethylnitrosamine carcinogenesis in the Syrian golden hamster.

Authors:  F Stenback; A Ferrero; R Montesano; P Shubik
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1973

2.  [Spontaneous tumors in Syrian golden hamsters (author's transl)].

Authors:  W Dontenwill; H J Chevalier; H P Harke; U Lafrenz; G Reckzeh; B Schneider
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1973-11-01

3.  Carcinogenic effects in the Syrian golden hamster of N-methyl-N-formylhydrazine of the false morel mushroom Gyromitra esculenta.

Authors:  B Toth; K Patil
Journal:  J Cancer Res Clin Oncol       Date:  1979-02-19       Impact factor: 4.553

4.  False morel mushroom Gyromitra esculenta toxin: N-methyl-N-formylhdrazine carcinogenesis in mice.

Authors:  B Toth; K Patil; J Erickson; R Kupper
Journal:  Mycopathologia       Date:  1979-09-17       Impact factor: 2.574

5.  Cirrhosis and liver tumours in a closed colony of golden hamsters.

Authors:  F C Chesterman; A Pomerance
Journal:  Br J Cancer       Date:  1965-12       Impact factor: 7.640

6.  A carcinogenic potency database of the standardized results of animal bioassays.

Authors:  L S Gold; C B Sawyer; R Magaw; G M Backman; M de Veciana; R Levinson; N K Hooper; W R Havender; L Bernstein; R Peto
Journal:  Environ Health Perspect       Date:  1984-12       Impact factor: 9.031

7.  CORRELATION BETWEEN THE CHEMICAL INDUCTION OF HYPERPLASIA AND OF MALIGNANCY IN THE BLADDER EPITHELIUM.

Authors:  D B CLAYSON; T A LAWSON; S SANTANA; G M BONSER
Journal:  Br J Cancer       Date:  1965-06       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.